Fasting and rapamycin: diabetes versus benevolent glucose intolerance

Volume: 10, Issue: 8
Published: Aug 13, 2019
Abstract
Rapamycin (Sirolimus) slows aging, extends life span, and prevents age-related diseases, including diabetic complications such as retinopathy. Puzzlingly, rapamycin can induce insulin sensitivity, but may also induce insulin resistance or glucose intolerance without insulin resistance. This mirrors the effect of fasting and very low calorie diets, which improve insulin sensitivity and reverse type 2 diabetes, but also can cause a form of glucose...
Paper Details
Title
Fasting and rapamycin: diabetes versus benevolent glucose intolerance
Published Date
Aug 13, 2019
Volume
10
Issue
8
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.